MXPA03004542A - Inhibidores de proteasa. - Google Patents
Inhibidores de proteasa.Info
- Publication number
- MXPA03004542A MXPA03004542A MXPA03004542A MXPA03004542A MXPA03004542A MX PA03004542 A MXPA03004542 A MX PA03004542A MX PA03004542 A MXPA03004542 A MX PA03004542A MX PA03004542 A MXPA03004542 A MX PA03004542A MX PA03004542 A MXPA03004542 A MX PA03004542A
- Authority
- MX
- Mexico
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25250800P | 2000-11-22 | 2000-11-22 | |
| PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03004542A true MXPA03004542A (es) | 2003-09-10 |
Family
ID=22956303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03004542A MXPA03004542A (es) | 2000-11-22 | 2001-11-19 | Inhibidores de proteasa. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1392657A4 (es) |
| JP (1) | JP2005513083A (es) |
| KR (1) | KR20040004445A (es) |
| CN (1) | CN1635903A (es) |
| AR (1) | AR034278A1 (es) |
| AU (1) | AU2001298052A1 (es) |
| BR (1) | BR0115473A (es) |
| CA (1) | CA2436850A1 (es) |
| CZ (1) | CZ20031403A3 (es) |
| HU (1) | HUP0301964A3 (es) |
| IL (1) | IL155997A0 (es) |
| MX (1) | MXPA03004542A (es) |
| NO (1) | NO20032328L (es) |
| PL (1) | PL366232A1 (es) |
| UY (1) | UY27032A1 (es) |
| WO (1) | WO2003053331A2 (es) |
| ZA (1) | ZA200303848B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| SK13632002A3 (sk) | 2000-03-21 | 2003-02-04 | Smithkline Beecham Corporation | C1-6-alkyl-4-amino-azepán-3-ónové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty |
| JP2004503502A (ja) * | 2000-06-14 | 2004-02-05 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
| CN101970007A (zh) | 2007-06-08 | 2011-02-09 | 日本化学医药株式会社 | 脑动脉瘤的治疗或预防药 |
| US20100331545A1 (en) | 2007-10-24 | 2010-12-30 | Nippon Chemiphar Co., Ltd. | Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002533397A (ja) * | 1998-12-23 | 2002-10-08 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
| SK13632002A3 (sk) * | 2000-03-21 | 2003-02-04 | Smithkline Beecham Corporation | C1-6-alkyl-4-amino-azepán-3-ónové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty |
| JP2004503502A (ja) * | 2000-06-14 | 2004-02-05 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
-
2001
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1392657A4 (en) | 2004-03-10 |
| CN1635903A (zh) | 2005-07-06 |
| JP2005513083A (ja) | 2005-05-12 |
| IL155997A0 (en) | 2003-12-23 |
| EP1392657A2 (en) | 2004-03-03 |
| CZ20031403A3 (cs) | 2003-10-15 |
| ZA200303848B (en) | 2004-06-28 |
| KR20040004445A (ko) | 2004-01-13 |
| CA2436850A1 (en) | 2003-07-03 |
| WO2003053331A3 (en) | 2003-11-13 |
| WO2003053331A2 (en) | 2003-07-03 |
| HUP0301964A3 (en) | 2007-09-28 |
| PL366232A1 (en) | 2005-01-24 |
| NO20032328L (no) | 2003-07-02 |
| UY27032A1 (es) | 2002-07-31 |
| BR0115473A (pt) | 2004-09-28 |
| NO20032328D0 (no) | 2003-05-22 |
| AR034278A1 (es) | 2004-02-18 |
| AU2001298052A1 (en) | 2003-07-09 |
| HUP0301964A2 (en) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03001780A (es) | Inhibidores de proteasa peptidomimeticos. | |
| AP2002002593A0 (en) | Protease inhibitors | |
| MXPA03008177A (es) | Inhibidores de metaloproteinasa.. | |
| GB0125445D0 (en) | Protease Inhibitors | |
| ZA200109890B (en) | Metalloprotease inhibitors. | |
| MXPA03008180A (es) | Inhibidores de metaloproteinasa. | |
| MXPA03001832A (es) | Derivados de hidroxamato utiles como inhibidores de desacetilasa. | |
| MXPA03005838A (es) | Inhibidores de antigenos de aparicion muy tardia-4. | |
| MXPA03008183A (es) | Inhibidores de metaloproteinasa. | |
| IL153421A0 (en) | Protease inhibitors | |
| EP1235577A4 (en) | PROTEASE INHIBITORS | |
| EP1232155A4 (en) | PROTEASE INHIBITORS | |
| IL151087A0 (en) | Protease inhibitors | |
| EP1229915A4 (en) | PROTEASE INHIBITORS | |
| EP1229912A4 (en) | PROTEASE INHIBITORS | |
| EP1229914A4 (en) | PROTEASE INHIBITORS | |
| EP1231921A4 (en) | PROTEASE INHIBITORS | |
| EP1351930A4 (en) | PROTEASE INHIBITORS | |
| EP1161237A4 (en) | PROTEASE INHIBITORS | |
| EP1233771A4 (en) | PROTEASE INHIBITORS | |
| EP1229911A4 (en) | PROTEASE INHIBITORS | |
| EP1401453A4 (en) | PROTEASE INHIBITORS | |
| EP1231923A4 (en) | PROTEASE INHIBITORS | |
| MXPA03004542A (es) | Inhibidores de proteasa. | |
| EP1232154A4 (en) | PROTEASE INHIBITORS |